US Stock Market Move | Weight loss drug sector stocks fall, Eli Lilly (LLY.US) plummets over 5%
Weight loss drug sector under pressure
On Thursday, the weight loss drug sector came under pressure. As of the time of writing, Eli Lilly (LLY.US) plummeted over 5%, with the company's weight loss drugs being added to the FDA review list, delaying the decision until April 10, 2026. Novo Nordisk A/S Sponsored ADR Class B (NVO.US) fell over 4%, while Pfizer Inc. (PFE.US) and Amgen (AMGN.US) dropped over 1%.
Related Articles
US Stock Market Move | Some nuclear power concept stocks are strengthening, with Talen Energy (TLN.US) rising more than 10%.
US Stock Market Move | Morgan Stanley(MS.US) rose more than 4% in Q4, with investment banking revenue soaring 47%.
US Stock Market Move | Burning Rock Biotech Ltd. Sponsored ADR Class A (BNR.US) rose more than 10% as it developed the OncoCompass technology to empower precise diagnosis and treatment of tumors.
US Stock Market Move | Some nuclear power concept stocks are strengthening, with Talen Energy (TLN.US) rising more than 10%.
US Stock Market Move | Morgan Stanley(MS.US) rose more than 4% in Q4, with investment banking revenue soaring 47%.
US Stock Market Move | Burning Rock Biotech Ltd. Sponsored ADR Class A (BNR.US) rose more than 10% as it developed the OncoCompass technology to empower precise diagnosis and treatment of tumors.
